user
cart
menu
orderQuote Inquiry / OrdercartCart
letter
Sign InRegister
langEnglisharrow

MIF

MIF

MIF Overview

Molecule Name
Macrophage migration inhibitory factor
Synonyms
MIF,GLIF,MMIF,GIF
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs1
Highest Development StageApproved
Target Synonym
EC:5.3.2.1，GIF，EC 5.3.3.12，EC 5.3.2.1，Macrophage Migration-Inhibitory Factors，Epididymis Secretory Sperm Binding Protein，EC:5.3.3.12，Phenylpyruvate Tautomerase，L-Dopachrome Tautomerase，MMIF，Glycosylation-inhibiting factor，L-dopachrome isomerase，MIF，Macrophage Migration Inhibitory Factor，Macrophage Migration Inhibitory Factor (Glycosylation-Inhibiting Factor)，GLIF
Background
Macrophage migration inhibitory factor(MIF) is also known as Glycosylation-inhibiting factor(GIF), L-dopachrome isomerase, L-dopachrome tautomerase, Phenylpyruvate tautomerase. Interacts with CXCR2 extracellular domain, CD74 extracellular domain, COPS5 and BNIPL. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

MIF Product List

Species
  • Human（1）
Tag
  • His Tag & Avi Tag（1）
Host
  • HEK293（1）
Conjugate
  • Biotin-labeled（1）
Grade
  • RUO（1）
Low Endotoxin
  • No（1）
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&PriceAdd to Cart
MIF
Avitag
MIF-H82E7
Biotinylated Human MIF Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Product InquiryRequest Customization
Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
IPG-1094IPG-1094; IPG-001Phase 2 ClinicalNanjing Immunophage Biotech Co Ltd
Brain metastases; Brain Neoplasms; Hematologic Neoplasms; Lupus Nephritis; Multiple Myeloma; Multiple Sclerosis; Psoriasis; Solid tumours
Details
TRP2-electroporated autologous dendritic cell therapy (Memorial Sloan-Kettering)Phase 1 ClinicalMemorial Sloan Kettering Cancer Center
Melanoma
Details
STP-1STP-1; STP1Phase 1 ClinicalStalicla Sa
Autism Spectrum Disorder
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
IbudilastKC-404; AV-411; MN-166ApprovedKyorin Pharmaceutical Co LtdKetas, Pinatos, EyevinalJapanAsthma; Multiple Sclerosis; NeuralgiaKyorin Pharmaceutical Co Ltd
Alcoholism; Amyotrophic Lateral Sclerosis; Asthma; Diabetic Neuropathies; Headache Disorders, Secondary; HIV Infections; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Neuralgia; Opioid-Related Disorders; Pneumonia, Viral; Substance-Related Disorders
Details
Customer Reviews
  • S***n2023-04-28
    Biotinylated Human MIF Protein, His,Avitag™
    This product was used for characterization of a novel therapeutic testing kinetics and affinity on SPR with a Cytiva BiotinCAPture kit. It worked phenomenally with both the novel approach and a positive control. Additionally, it was used with a Streptavidin coated ELISA plate (also from Acro), results were phenomenal with that approach as well. Overall, this product has been well received by our team and we have already ordered more to continue testing.